NASDAQ:MTBC - Nasdaq - US14167R1005 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to MTBC. MTBC was compared to 36 industry peers in the Health Care Technology industry. MTBC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, MTBC is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | N/A | ||
ROE | N/A | ||
ROIC | 4.81% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 3.77% | ||
PM (TTM) | N/A | ||
GM | 38.04% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0.06 | ||
Altman-Z | 2.01 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.21 | ||
Quick Ratio | 1.19 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 5.4 | ||
EV/EBITDA | 2.55 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:MTBC (1/9/2023, 8:23:58 PM)
3.13
+0.34 (+12.19%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.33 | ||
P/FCF | 5.4 | ||
P/OCF | 2.24 | ||
P/B | 0.46 | ||
P/tB | 4.01 | ||
EV/EBITDA | 2.55 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | N/A | ||
ROE | N/A | ||
ROCE | N/A | ||
ROIC | 4.81% | ||
ROICexc | 4.99% | ||
ROICexgc | 43.34% | ||
OM | 3.77% | ||
PM (TTM) | N/A | ||
GM | 38.04% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0.06 | ||
Debt/EBITDA | 0.03 | ||
Cap/Depr | 103.98% | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.21 | ||
Quick Ratio | 1.19 | ||
Altman-Z | 2.01 |